What Happened? Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) fell 9.7% in the afternoon session ...

Henry Schein Inc. stock down on Q2 earnings, misses EPS but beats sales. Total net sales up 3.3%, $23M in restructuring costs ...

Despite Henry Schein’s recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.

On Feb. 25, Henry Schein reported its fourth-quarter results, posting a 5.8% year-over-year revenue increase to $3.2 billion, fueled by strong growth in dental and medical distribution.